Post-Discharge Care for HIPEC Patients

Expected Hospital Course and Discharge Timing

The American Society of Anesthesiologists recommends that patients should not be discharged until they demonstrate adequate oral intake, pain control, and stable vital signs 2
The median hospital stay ranges from 8-24 days, with high-quality trials showing stays of approximately 10 days for HIPEC combined with cytoreductive surgery 1
Grade 3-4 toxicities occur in approximately 27% of patients during the initial hospitalization, similar to cytoreductive surgery alone 1

Patients should be instructed to monitor for fever, increasing abdominal pain, or purulent drainage from incisions 3
The National Comprehensive Cancer Network recommends monitoring for signs of sepsis, such as fever >38.5°C, and immediate medical evaluation is required for temperature >38.5°C or signs of sepsis 3

The American Society of Anesthesiologists recommends that patients should have prescriptions filled before discharge and clear instructions on when to escalate to combination therapy for nausea and vomiting management 2
Olanzapine 5-10 mg PO daily should be prescribed as first-line agent for breakthrough nausea/vomiting 1
Patients should maintain oral fluid intake of at least 2 liters daily and report signs of dehydration (decreased urine output, dizziness, dry mucous membranes) 2

Anemia (67% vs 50% in controls) and creatinine elevation (15% vs 4% in controls) are significant complications 4, 3
Arrange follow-up laboratory testing within 7-10 days of discharge to monitor renal function and hemoglobin 2

The National Comprehensive Cancer Network recommends that patients must complete a minimum of 3 cycles (preferably 6 total cycles including neoadjuvant) of systemic chemotherapy 1
Oncology follow-up should be scheduled within 2-3 weeks of discharge to plan adjuvant therapy timing 3
Delayed initiation of adjuvant chemotherapy is expected but should not prevent completion of the full treatment course 1